International Journal of Clinical Pediatrics, ISSN 1927-1255 print, 1927-1263 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Int J Clin Pediatr and Elmer Press Inc |
Journal website https://ijcp.elmerpub.com |
Case Report
Volume 000, Number 000, April 2025, pages 000-000
Successful Treatment of COVID-19 and Multisystem Inflammatory Syndrome in Children Associated Severe Aplastic Anemia With Unrelated Donor Stem Cell Transplantation
Figures
Tables
Test | Results |
---|---|
BCOR: BCL6 corepressor; BMF: bone marrow failure; C: complement; CMV: cytomegalovirus; DEB: diepoxybutane; eADA: erythrocyte adenosine deaminase; EBV: Ebstein-Barr virus; ERCC4: ERCC excision repair 4, endonuclease catalytic subunit; HemeSTAMP assay: Stanford Tumor Actionable Mutation Panel for Hematopoietic and Lymphoid Neoplasms (CPT code 81455); Hgb: hemoglobin; HHV6: human herpes virus 6; HIV: human immunodeficiency virus; HLA: human leukocyte antigen; HSV: herpes simplex virus; HTLV: human T-lymphotropic virus; LDH: lactate dehydrogenase; NK: natural killer; PNH: paroxysmal nocturnal hemoglobinuria; PT: prothrombin time; PTT: partial thromboplastin time; RBC: red blood cell; TSH: thyroid-stimulating hormone; VUS: variant of unknown significance; WBC: white blood cell. | |
Coombs | Negative |
Type & Screen | A+ |
Flow for PNH | Positive (0.096%) |
Hepatitis screen: A, B, C, E | Negative |
Coagulation panel (s) | PTT 40.3, PT 15.4 |
6-panel telomeres | Normal |
Immunoglobulins | Direct anti-platelet IgM strong positive, IgG negative; indirect antibody negative |
T-/B-cell subsets | Decreased WBCs, NK cells, Pan B cells |
C3, C4 | Normal |
EBV | Past infection |
CMV | Negative |
HIV | Negative |
Parvovirus | Negative |
HHV6 | Negative |
HSV-1, 2 | HSV-1 antibodies detected |
HTLV-1, 2 | Negative |
Varicella | Immune |
HLA typing family | 5/10 match with subject |
Hgb F | 1.1% (normal) |
LDH/uric acid | Normal |
Thyroid function panel (T3, T4, TSH) | Normal |
Haptoglobin | Normal |
BMF gene sequencing | VUS in one copy of ERCC4 |
HemeSTAMP (blood) | BCORY497, BCORK1543fs, PIGA p.Leu175Pro variant |
Amylase isoenzymes | Normal |
Methylmalonic acid | Normal |
Organic acids, urine | Negative |
eADA | Normal |
Flow cytometry for leukemia/lymphoma | Normal T- and B-cell populations |
RBC folate | Normal |
Homocysteine | Normal |
Copper | Normal |
Zinc | Low |
Haptoglobin | Normal |
DEB chromosomal test for Fanconi anemia | Negative |
BMF panel | ERCC4 (VUS) |
Reference | Number of patients | Hematological presentation | Age (years) | Gender | Treatment | Transplant | Comorbidity | Outcome |
---|---|---|---|---|---|---|---|---|
Cs-A: cyclosporine-A; Epo: erythropoietin; h-ATG: horse ATG; IST: immunosuppressive therapy; IVIG: intravenous immunoglobin; PNH: paroxysmal nocturnal hemoglobinuria. | ||||||||
Amanati et al, 2022 [5] | 1 | Pancytopenia | 6 | F | Antibacterial and antifungal | No | None | Neutropenic enterocolitis and death due to invasive fungal infection |
Chakravarthy et al, 2022 [6] | 2 | Severe aplastic anemia; severe aplastic anemia | 12; 18 | F; M | IST; IST with eltrombopag | No; No | None; None | Full recovery; full recovery |
Figlerowicz et al, 2020 [3] | 1 | Severe aplastic anemia | 6 | F | IVIG, IST, antivirals, antifungals, antibiotics, convalescent plasma | No | None | Unknown |
Lee et al, 2022 [1] | 1 | Severe aplastic anemia | 21 | M | Cs-A, eltrombopag, h-ATG, eculizumab | No | PNH | Clinical remission at 6 months |
Mariani and Liu, 2020 [2] | 1 | Pancytopenia | 0.4 | F | Methylprednisone | No | None | Recovery in 6 weeks |
Otieno et al, 2021 [4] | 1 | Pancytopenia | 19 | M | Eculizumab, ravulizumab | Referred for transplant | PNH | Persistent pancytopenia, unknown outcome |
Ranjima, 2021 [7] | 1 | Aplastic anemia | 4 | F | Methylprednisone, filgrastim, Epo | No | None | Unknown |